A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 253 participants.
Also called NCT01056731
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 253 participants
- Sponsor
- Registry
-
NCT01056731
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Venezuela
- Registry status
- Completed
Technical summary
Registry record NCT01056731. Allocation not applicable; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.
- Acronym
- ANDROMEDA
- Condition
- High Blood Pressure
- Intervention (Drug)
- Aliskiren and HCTZ
- Lead sponsor
- Novartis
Record details
- Record id
cardio:ct-nct01056731- Content hash
3b85fdacfe9819dc48d98c68917df775fb1cf3ee8f692ea300e16d4ed2db3758